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Abstract
Introduction
Plasmodium vivax is the most prevalent malaria species in the American region. Brazil
accounts for the higher number of the malaria cases reported in pregnant women in the
Americas. This study aims to describe the characteristics of pregnant women with malaria
in an endemic area of the Brazilian Amazon and the risk factors associated with prematurity
and low birth weight (LBW).
Methods/Principal Findings
Between December 2005 and March 2008, 503 pregnant women with malaria that attended
a tertiary health centre were enrolled and followed up until delivery and reported a total of
1016 malaria episodes. More than half of study women (54%) were between 20–29 years
old, and almost a third were adolescents. The prevalence of anaemia at enrolment was
59%. Most women (286/503) reported more than one malaria episode and most malaria epi-
sodes (84.5%, 846/1001) were due to P. vivax infection. Among women with only P. vivax
malaria, the risk of preterm birth and low birth weight decreased in multigravidae (OR, 0.36
[95% CI, 0.16–0.82]; p = 0.015 and OR 0.24 [95% CI, 0.10–0.58]; p = 0.001, respectively).
The risk of preterm birth decreased with higher maternal age (OR 0.43 [95% CI, 0.19–0.95];
p = 0.037) and among those women who reported higher antenatal care (ANC) attendance
(OR, 0.32 [95% CI, 0.15–0.70]; p = 0.005).
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Conclusion
This study shows that P. vivax is the prevailing species among pregnant women with
malaria in the region and shows that vivax clinical malaria may represent harmful conse-
quences for the health of the mother and their offsprings particularly on specific groups
such as adolescents, primigravidae and those women with lower ANC attendance.
Introduction
In 2011 the region of the Americas reported nearly half million malaria cases, 77% of them
were due to Plasmodium vivax. According to the World Health Organization, the American
region was responsible in the same year for nearly 20% of the total P. vivaxmalaria cases
reported in the world [1].
In 2007 it was estimated that 92.9 million pregnancies occurred in P. vivax endemic areas
and of them that 2.9 million pregnancies (3.1%) occurred in the American region [2]. In 2008 a
total of 5,740 malaria cases were reported in pregnant women in the Americas, but it is esti-
mated that the number of malaria cases in pregnant women was much higher. A 75% of the
reported cases in the region were from Brazil (4315/5740) [3] and of the latter, 571 cases were
reported only in the Manaus city area, representing 13.2% of Brazil cases and 10% of the Amer-
icas [4].
It is well known that pregnant women have a higher risk for P. falciparum infection and dis-
ease, and the impact of P. falciparum infection on pregnancy outcomes, such as maternal anae-
mia, low birth weight (LBW) and prematurity are well documented, at least in sub-Saharan
Africa [5, 6]. There is evidence that P. vivax infection can be associated with low birth and
anaemia, as it has been described in Thailand, India and Papua (Indonesia) [7–12]. In the
region of the Americas, several studies have described that P. vivax infection during pregnancy
is associated with maternal anaemia, low birth weight, preterm delivery and miscarriage
[13–18].
The current study aims to characterize malaria among pregnant women from an endemic
area of the Brazilian Amazon, and to assess in this population group the risk factors associated
with poor pregnancy outcomes.
Methods
Ethical aspects
The study protocol was approved by the Research Ethics Committee of the Fundação de Medi-
cina Tropical Dr. Heitor Vieira Dourado (FMT-HVD) (study registration No. 0836-05/2005)
and the same committee approved an amendment to the protocol in 2010 (study registration
No. 2013). We obtained informed written consent from all participants and from the guardians
on behalf of the pregnant women less than 18 years old.
Study area
The city of Manaus (3° 1'S, 60° 02'O) is located in the Brazilian Amazon region, capital of the
Amazonas state, northern Brazil. Manaus is one of the top six cities contributing to the Gross
National Product, which together represent approximately 25% of the Brazilian Gross National
Product. The population of the city of Manaus was of 1,802.525 inhabitants according to the
2010 census. It is the most populous city in the northern region and the seventh in Brazil. The
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majority of the population (99.5%) lives in urban areas [19]. Approximately 38,500 live births
are recorded every year in Manaus, and most births (99%) are attended by skilled health per-
sonnel in health facilities and 80% of pregnant women report at least four ANC [20]. The
Annual Parasitic Index in Manaus was of 39.2/1,000 inhabitants in 2005 and 14.6/1,000 inhabi-
tants in 2008, being classified as a medium risk malaria transmission area (10 to 49.9 cases/
1.000 inhabitants) [21].
The Brazilian National Malaria Control Program relies on early diagnosis and treatment of
malaria cases in general population [22]. Since 2006 the Ministry of Health recommends active
detection of malaria infection with microscopy at each ANC visit to all pregnant women living
in the Amazon region [23]. In Brazil, malaria is a notifiable disease and every confirmed case
has to be reported through a national surveillance system (SIVEP) that includes information
on pregnancy status [4]. All malaria cases are laboratory-confirmed by light microscopy.
Malaria treatment is given for free and provided exclusively through the public health system.
Standard treatment for non-severe P. vivaxmalaria in pregnant women consists of oral chloro-
quine (1500 mg, over three days) followed by weekly prophylaxis with chloroquine (300 mg,
over 12 weeks). During the study period weekly prophylaxis recommendation changed from
getting started after the second P. vivaxmalaria episode during pregnancy to start after the first
one. The treatment is completed with primaquine six months after delivery [24]. The chloro-
quine resistance in the area is 10% in the general population [25]. There is no data available
about therapeutic failure or frequency of relapses among pregnant women in the Manaus area
[26].
Study population and study design
From December 2005 to March 2008, pregnant women of any gestational age attending to the
outpatient clinic of the FMT-HVD, and diagnosed with malaria due to any Plasmodium species
confirmed by microscopy, were invited to participate in the study. The FMT-HVD is a tertiary
health care centre that runs a passive case detection system (outpatient clinic) for pregnant
woman among other curative services. After written informed consent was given, blood sam-
ples were collected for parasitaemia determination and anaemia screening. According to Bra-
zilian national guidelines, all confirmed malaria cases received treatment, and clinical follow
up was done on days (D) 3, 7, 14, 21, 28 and 35 after treatment initiation. After D35, follow up
visits were scheduled every four weeks until delivery. In the event of a new malaria episode the
woman initiated the same sequence of follow up visits again. All pregnant women with anae-
mia received ferrous sulphate and folic acid according to the Brazilian national guidelines.
Information on the number of antenatal visits, date of birth, birth weight, gender of the
newborn, and the occurrence of any congenital malformation was retrieved through the Live
Birth Information System (SINASC) [27]. Birth weight was measured on a digital scale at the
health facility level by nurses within the first hour after birth. Those women who had miscar-
riage, stillbirth or multiple gestations (twins or triplets) as a pregnancy outcome were excluded
from the analysis. The gestational age was assessed by ultrasound, or in the absence of this, by
the date of the last menstrual period. The SINASC database from 2005 to 2008 for the Amazo-
nas state was provided by the Foundation for Health Surveillance of the Amazon (FVS). All
other variables were obtained at the time of each scheduled visits by study staff.
Definitions
Amalaria case was defined as the presence of asexual forms of any Plasmodium species in
peripheral blood of any density by microscopy in pregnant women with symptoms. For the
purpose of the analysis, the duration of any single malaria episode was estimated as 28 days, in
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order to distinguish between the same episode and a new one. Low birth weight was defined as
a birth weight less than 2,500 g. Low birth weight was classified, in turn, as very low birth
weight (between 1,000 and 1,499 g), and as extreme low birth weight (less than 1,000 g). For
the analysis of birth weight in relation to gestational age, Brazilian standardized growth curves
[28] were used to avoid any deviations from the Lubchenco growth reference curves that are
based on Caucasian populations in industrialized countries [29]. Sex specific growth curves
were calculated and compared, given the gender specific differences in foetal growth described
in the literature [30]. Newborns were classified as large for gestational age when the estimate
was higher than the 90th percentile, appropriate for gestational age when it was between the
10th and the 90th percentiles, and small for gestational age when it was below the 10th percentile
[28]. The intra-uterine growth retardation (IUGR) was defined as the newborn small for gesta-
tional age. Anaemia during pregnancy was defined as a haemoglobin level less than 11 mg/dL.
Mild, moderate and severe anaemia were defined as a haemoglobin levels of 9–10.9 mg/dL,
7–8.9 mg/dL, and less than 7 mg/dL, respectively. Prematurity was defined as a gestational age
less than 37 weeks.
Statistical analysis
All clinical and laboratory data from patients were collected through standardized question-
naires and recorded in Epi Info software (version 6.04, CDC, Georgia, USA). Analysis was per-
formed using STATA software (version 12, College Station, Texas, USA). The analysis was
stratified in two groups: 356 women with only P. vivax during pregnancy and 503 women with
any Plasmodium species during pregnancy. The comparison between the proportions in the
group with and without prematurity and LBW, respectively, was validated by the chi-square
statistical test. To calculate the odds ratio (OR) logistic regression analysis was used. To evalu-
ate the association between maternal factors, and prematurity and LBWmultivariate analysis
was performed using backward stepwise logistic regression, removing variables with a p value
of 0.05. All episodes occurred during pregnancy were included and were further categorised in
single episode, two episodes or at least 3 episodes during pregnancy.
Results
Between December 2005 and March 2008, a total of 583 pregnant women were enrolled in the
study at the FMT-HVD, of which 503 were finally included in the analysis (Fig 1).
Characteristics of the study pregnant women and their newborns
See Table 1 for baseline characteristics of study women. More than half of study women (54%,
274/502) were between 20 and 29 years old, and almost a third were adolescents. Most women
were in the second (170/440) or third trimester (213/440) at enrolment (39% and 48%, respec-
tively) and thirteen percent of study pregnant women were in their first trimester. Most
women had at least primary studies (68%, 323/475) and were residents in the Manaus area
(72%, 353/488). More than hundred women (130/488) came from other cities in the Amazonas
region, three women came from another Brazil state (Roraima and Rondônia states) and two
women came from border nations (Republic of Guyana and French Guyana). Most of them
had at least four ANC visits (73%, 354/486). The prevalence of anaemia at enrolment was 59%
(265/449; haemoglobin mean ± SD of 10.6 ± 1.5), of which 77% (204/265) was mild anaemia
and 1.5% severe anaemia.
Table 2 summarizes newborns characteristics. The prevalence of preterm birth was 14.8%
(65/438). The prevalence of low birth weight was 9% (45/503), of which four cases were very
low birth weight, and four cases were extreme low birth weight. Most newborns (78.4%,
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333/425) had a birth weight appropriate for gestational age, 12.7% (54/425) were large for ges-
tational age, and 8.9% (38/425) were small for gestational age (IUGR); no differences were
found by gender among babies with IUGR (8.1% in male and 9.7% in female newborns,
p = 0.686) (see Fig 2). The inter-rater agreement between the study cohort whose birth weight
was retrieved from the SINASC system and a sub-sample of newborns (n = 98) whose birth
weight was collected from the newborn card by study staff was assessed using the Kappa statis-
tic, showing a high correlation agreement [Kappa score 0.951 (95% CI 0.855 to 1.000)].
Frequency of Plasmodium species during pregnancy
Plasmodium vivax infection frequency in the first malaria episode during the pregnancy was
80.5% (395/491), followed by Plasmodium falciparum (18.1%, 89/491), and mixed P. falcipa-
rum and P. vivax infection (1.4%, 7/491). Most women (56.9%, 286/503) reported two or more
malaria episodes during the same pregnancy. The 503 study women reported a total of 1016
malaria episodes (ranging from one to eight episodes per woman). Most episodes were due to
P. vivax (84.5%, 846/1001), followed by P. falciparum (13.9%, 139/1001), and mixed P. falcipa-
rum and P. vivax infection (1.6%, 16/1001). Most women (72.1%, 356/494) had only malaria
due to P. vivax during pregnancy. The frequency distribution of P. vivax in the first malaria
episode during pregnancy among pregnant women increased over the study period from
76.8% (199/259) in the first half of the study to 84.5% (196/232) in the second half of the study.
The frequency of P. falciparum decreased from 20.9% (54/259) in the first half of the study to
15.1% (35/232) in the second half over the same period.
Risk factors for prematurity
Table 3 shows the analysis of maternal factors and their association with the risk of preterm
birth. Among women with only P. vivaxmalaria during pregnancy, the risk of premature deliv-
ery decreased with higher maternal age at enrolment (OR for women 20 or more years old,
0.43 [95% CI, 0.19–0.95]; p = 0.037), higher parity (OR for two or more pregnancies, 0.36 [95%
CI, 0.16–0.82]; p = 0.015) and in those women with higher attendance to ANC (OR for four or
more ANC visits, 0.32 [95% CI, 0.15–0.70]; p = 0.005). Maternal anaemia at enrolment was sig-
nificantly associated with an increased risk of premature delivery (OR, 2.35 [95% CI, 1.11–
5.01]; p = 0.026) in the univariate analysis but this was not confirmed in the adjusted analysis.
Fig 1. Study profile.
doi:10.1371/journal.pone.0144399.g001
Plasmodium vivax in Brazilian Pregnant Women
PLOSONE | DOI:10.1371/journal.pone.0144399 December 16, 2015 5 / 14
The reduced risk of preterm birth in women of higher maternal age and greater attendance
to ANC was also seen among women with malaria due to any Plasmodium species (OR for
women 20 or more years old, 0.54 [95% CI, 0.29–0.99]; p = 0.047, and OR for having reported
four or more ANC visits, 0.49 [95% CI, 0.28–0.87]; p = 0.014) (see Table 3).
Risk factors for low birth weight
Table 4 shows the analysis of maternal factors and their association with LBW. In women with
only P. vivaxmalaria during pregnancy, the risk of LBW decreased with higher parity (OR for
mothers with two or more pregnancies, 0.24 [95% CI, 0.10–0.58]; p = 0.001).
In the group of women with malaria due to any Plasmodium species, the risk of LBW was
highest among primigravidae and in those women with anaemia at the time of enrolment (see
Table 1. Baseline characteristics of study pregnant women.
Characteristics n (%) or Mean ± SDa
Age at enrolment (years) (n = 502) 23.7 ± 6.1
Age at enrolment (n = 502) 9 to 19 141 (28)
20 to 29 274 (54)
30 to 39 79 (16)
 40 8 (2)
Gravidity (n = 489) Primigravidae 150 (31)
2 to 3 pregnancies 205 (42)
 4 pregnancies 134 (27)
Gestational age at enrolment (weeks) (n = 440) 23.8 ± 8.9
Gestational age at enrolment (n = 440)b 1st trimester 57 (13)
2nd trimester 170 (39)
3rd trimester 213 (48)
Level of education (n = 475) Illiterate 4 (1)
Primary school 323 (68)
Secondary school 137 (29)
Higher education 11 (2)
Place of residence (n = 488) Manaus area 353 (72)
Outside Manaus area 135 (28)
Total number of antenatal visits(throughout pregnancy) (n = 486) None 26 (5)
1 to 3 106 (22)
4 to 6 208 (43)
 7 146 (30)
Clinical malaria episodes during pregnancy (any Plasmodium species) (n = 503) 1 217 (43.2)
2 146 (29)
 3 140 (27.8)
Haemoglobin level at enrolment (mg/dL) (n = 449) 10.6 ± 1.5
Anemia at enrolment (n = 449) Yes 265 (59)
Categorization for anemia at enrolment (n = 265) c Mild anemia 204 (77)
Moderate anemia 57 (21.5)
Severe anemia 4 (1.5)
aStandard deviation.
b1st trimester: 0–12 weeks, 2nd: 13–24 weeks, 3rd: 25–40 weeks.
cMild anemia: haemoglobin levels of 9–10.9 mg/dL, moderate: 7–8.9 mg/dL, severe: < 7 mg/dL.
doi:10.1371/journal.pone.0144399.t001
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Table 4). There was a trend for an increased risk of low birth weight among the youngest moth-
ers, but this was not confirmed in the multivariate analysis.
Discussion
This study describes results on poor pregnancy outcomes among the largest series to date of
pregnant women with clinical malaria in the American region. Among pregnant women with
malaria, babies born to primigravidae and those who reported lesser attendance to ANC had
an increased risk of suffering from low birth weight and prematurity. Also, the results serves as
a paradigm to illustrate the pattern in the malaria transmission dynamics over the last years in
the Amazon area where Plasmodium vivax has become the predominant species, and show
that P. vivaxmalaria might be responsible for negative consequences of malaria during preg-
nancy in the region.
In this study, primigravidae with malaria were found to be at a higher risk for LBW and pre-
term delivery compared to multigravidae. This is consistent with previous data from other
vivax malaria endemic areas [9] and from P. falciparum stable transmission areas as in sub-
Saharan Africa [5]. Moreover, most women (82%) diagnosed with malaria in this series were
young (less than 30 years old) and nearly a third of study women were adolescents (less than
19 years old). This observation may be explained by the fact that the rate of adolescent preg-
nancies in Northern Brazil is the highest rate in the country, and that young women are at a
greater risk for malaria infection [5, 31]. The latter is well documented for P. falciparum
endemic areas, where young mothers are more likely to suffer from malaria infection and its
adverse effects than older ones, but few studies have reported this for P. vivax [5, 17, 32].
Most women in the study (73%) attended to ANC at least four times during pregnancy,
according to World Health Organization recommendations, which is consistent with the ante-
natal care coverage data reported in the area. Nevertheless more than a quarter of them had
Table 2. Baseline characteristics of newborns of study pregnant women.
Characteristics n (%) or
Mean ± SDa
Gender (n = 501) Male 252 (50.5)
Female 249 (49.5)
Birth weight (g) (n = 503) 3142 ± 558
Low birth weight (<2500 g) (n = 503) Yes 45 (9)
Categorization for low birth weight (n = 45) Low birth weight 37 (82)
Very low birth weight 4 (9)
Extreme low birth weight 4 (9)
Premature delivery (< 37 weeks) (n = 439) Yes 65 (14.8)
Classiﬁcation by birth weight and gestational age
(n = 425)b
Large for gestational age (LGA) 54 (12.7)
Appropriate for gestational age
(AGA)
333 (78.4)
Small for gestational age
(SGA)c
38 (8.9)
Congenital malformation (n = 454)d Yes 2 (0.4)
aStandard deviation.
bLGA >90th percentile; AGA: 10th-90th percentile; SGA < 10th percentile [28].
cThe intra-uterine growth retardation (IUGR) was deﬁned as the newborn small for gestational age.
dDetermination by clinical examination.
doi:10.1371/journal.pone.0144399.t002
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less than the recommended number of visits, and this was exactly the group who showed the
greater risk of suffering the negative effects of malaria during pregnancy. The reasons behind
poor utilization of antenatal care services in this area are still unknown. The health seeking
behaviour, barriers to access and use of health services, or other determinants associated with
economic, environmental, or cultural factors could explain poor compliance.
The total of malaria episodes included in this study (n = 1016) represented 67.9% out of the
1496 malaria episodes in pregnant women reported in the Manaus area during the study period
[4]. In this study, after the first malaria episode, every single study woman were encouraged to
attend several follow up visits that included active detection of Plasmodium infection. This
screening was performed monthly until delivery allowing the detection of any subsequent
infection, regardless the presence of symptoms. Secondly, the study women followed weekly
chemoprophylaxis with chloroquine until delivery. The positive effect of this intervention on
Fig 2. Correlation between gestational age and birth weight and graphical representation of the 10th and 90th percentiles for females (A) and
males (B) based on Brazilian-specific growth curves. SGA: Small for gestational age (< 10th percentile); AGA: Appropriate for gestational age (10th-90th
percentile); LGA: Large for gestational age (>90th percentile); LBW: Low birth weight (<2500 g); Premature newborn (< 37 weeks). The intra-uterine growth
retardation (IUGR) was defined as the newborn SGA. No differences were found by gender to IUGR (p = 0.686), LBW (p = 0.406) and prematurity (p = 0.968).
doi:10.1371/journal.pone.0144399.g002
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poor pregnancy outcomes, such as LBW and maternal anaemia, and prevention of relapses,
has been demonstrated in several studies, yet none of the studies included pregnant women
from Latin America [33, 34]. It should be noted that, among study women, this prompt detec-
tion and treatment of any malaria infection together with the prophylactic regimen may have
had an effect in decreasing the risk of negative outcomes, as these interventions would have
curtailed infections at an early stage, differently to what might occur in the group of pregnant
women that did not participate in the study [9].
Interestingly, this study reveals that more than one third of the study women (36%) had
more than one malaria episode during the same pregnancy despite the weekly
Table 3. Risk factors for premature delivery among study pregnant women with malaria.
Maternal risk factors Only P. vivax during pregnancy (n = 356) any Plasmodium species (n = 503)
Univariate model Multivariate model Univariate model Multivariate model
ORa (95% CI)b P valuec ORa (95% CI)b P valuec ORa (95% CI)b P valuec ORa (95% CI)b P valuec
Age at enrolment
(years)
< 20 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
 20 0.33 (0.17–0.63) 0.001 0.43 (0.19–0.95) 0.037 0.43 (0.25–0.72) 0.001 0.54 (0.29–0.99) 0.047
Gravidity Primigravidae 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
 2 pregnancies 0.42 (0.22–0.79) 0.007 0.36 (0.16–0.82) 0.015 0.55 (0.32–0.93) 0.026 0.59 (0.32–1.12) 0.106
Gestational age at
enrolment
1st trimester 1 . . . . . . 1 . . . . . .
2nd/3rd trimester 1.31 (0.49–3.54) 0.589 1.44 (0.63–3.32) 0.390
Level of education
(n = 475)
Illiterate/ Primary
school
1 . . . . . . 1 . . . . . .
Secondary school/
Higher education
0.78 (0.41–1.51) 0.467 0.82 (0.47–1.43) 0.481
Place of residence
(n = 488)
Manaus area 1 . . . . . . 1 . . . . . .
Outside Manaus
area
0.74 (0.35–1.57) 0.433 0.99 (0.57–1.74) 0.985
Total number of
antenatal visits
(throughout
pregnancy)
< 4 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
 4 0.45 (0.23–0.87) 0.018 0.32 (0.15–0.70) 0.005 0.50 (0.29–0.86) 0.013 0.49 (0.28–0.87) 0.014
Clinical malaria
episodes during
pregnancy (any
Plasmodium
species)
1 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
 2 0.68 (0.37–1.27) 0.226 0.50 0.25–1.03) 0.060 0.66 (0.39–1.09) 0.106 0.68 (0.40–1.17) 0.164
Plasmodium
species at ﬁrst
episode in the
pregnancy
P. vivax . . . . . . . . . 1 . . . . . .
P. falciparum . . . . . . . . . 1.29 (0.68–2.43) 0.419
P. falciparum/
vivax
. . . . . . . . . 2.16 (0.41–
11.44)
0.364
Anemia at
enrolment
No anemia 1 . . . . . . 1 . . . . . . 1 . . . . . .
Overall anemia 2.35 (1.11–5.01) 0.026 2.09 (0.94–4.65) 0.072 1.62 (0.92–2.86) 0.097
aOdds Ratio.
b95% conﬁdence interval.
cChi-squared test.
doi:10.1371/journal.pone.0144399.t003
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chemoprophylaxis with chloroquine. The contraindication during pregnancy of radical cure
with primaquine due to safety issues, putting women at a higher risk of subsequent episodes, as
well as the chloroquine resistance reported in the area may explain this finding. To date, no
study has shown if pregnant women have an increased risk of relapses compared to non-preg-
nant populations. In a Cochrane meta-analysis aimed to compare alternative primaquine regi-
mens for preventing relapses in people with P. vivaxmalaria, the frequency of relapses in
control groups (no primaquine) was 20%, but this review did not include data from pregnant
women or from Latin America [35]. Although the design of the current study does not allow
showing if this risk is higher among pregnant women, it reminds that these women are more
Table 4. Risk factors for low birth weight among study pregnant women with malaria.
Maternal risk factors Only P. vivax during pregnancy (n = 356) any Plasmodium species (n = 503)
Univariate model Multivariate model Univariate model Multivariate model
ORa (95% CI)b P valuec ORa (95% CI)b P valuec ORa (95% CI)b P valuec ORa (95% CI)b P valuec
Age at enrolment
(years)
< 20 1 . . . . . . 1 . . . . . .
 20 0.42 (0.19–0.91) 0.029 0.45 (0.24–0.84) 0.012
Gravidity Primigravidae 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
 2 pregnancies 0.31 (0.14–0.68) 0.004 0.24 (0.10–0.58) 0.001 0.36 (0.19–0.68) 0.002 0.31 (0.16–0.60) 0.001
Gestational age at
enrolment
1st trimester 1 . . . . . . 1 . . . . . .
2nd/3rd trimester 1.01 (0.29–3.55) 0.993 1.25 (0.43–3.67) 0.685
Level of education
(n = 475)
Illiterate/ Primary
school
1 . . . . . . 1 . . . . . .
Secondary
school/ Higher
education
0.85 (0.37–1.94) 0.697 0.67 (0.32–1.40) 0.284
Place of residence
(n = 488)
Manaus area 1 . . . . . . 1 . . . . . .
Outside Manaus
area
0.65 (0.24–1.77) 0.402 0.75 (0.36–1.56) 0.444
Total number of
antenatal visits
(throughout
pregnancy)
< 4 1 . . . . . . 1 . . . . . .
 4 0.70 (0.30–1.68) 0.429 0.85 (0.43–1.68) 0.636
Clinical malaria
episodes during
pregnancy (any
Plasmodium
species)
1 1 . . . . . . 1 . . . . . .
 2 0.60 (0.28–1.30) 0.194 0.78 (0.42–1.43) 0.416
Plasmodium species
at ﬁrst episode in the
pregnancy
P. vivax . . . . . . . . . 1 . . . . . .
P. falciparum . . . . . . . . . 1.39 (0.66–2.93) 0.390
P. falciparum/
vivax
. . . . . . . . . 1.83 (0.21–
15.65)
0.582
Anemia at enrolment No anemia 1 . . . . . . 1 . . . . . . 1 . . . . . . 1 . . . . . .
Overall anemia 2.23 (0.86–5.78) 0.099 2.56 (0.97–6.76) 0.059 1.93 (0.94–3.98) 0.073 2.14 (1.03–4.45) 0.043
aOdds Ratio.
b95% conﬁdence interval.
cChi-squared test.
doi:10.1371/journal.pone.0144399.t004
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vulnerable to P. vivaxmalaria since radical treatment of P. vivax infections with primaquine is
contraindicated during pregnancy.
The prevalence of maternal anaemia found in this study (59%) was considerably higher
compared with the prevalence of anaemia found among women attending routine ANC from
two studies conducted in the area in women with similar characteristics attending the routine
antenatal care, being at 26% in 2008 [36] and at 30%, in 2009–2010 [A. Bardají, personal com-
munication]. This finding supports that P. vivaxmalaria can be a considerable cause of mater-
nal morbidity, which is consistent with previous studies from this and other P. vivax endemic
areas [9–11, 16].
The change in the distribution of species observed over the study period, showing that P.
vivax gradually prevailed over P. falciparum, are aligned with the change in the pattern
observed in general population in this region [22]. This also includes a reduction in the malaria
incidence in the region. The treatment guidelines for P. vivaxmalaria have not changed in
recent years in Brazil [22]. Thus, these changes might be explained by the significant expansion
and strengthening of the diagnosis network towards the peripheral areas of the Manaus city,
which allowed to improve the case management, together with the introduction of Artemisi-
nin-based Combination Therapy for the treatment of P. falciparum malaria in 2006.
The prevalence of LBW seen was similar to that observed in the general population (8.1%),
which is similar in terms of demographic and social characteristics to that in our study [20].
LBW was primarily associated with premature delivery, and with foetal growth restriction to a
lesser extent; however the prevalence of premature delivery showed more than two-fold
increase with respect to the general population of Manaus (14.8% vs. 6.6%) [20]. One hypothe-
sis that might explain the higher frequency of prematurity but not of LBW would be that in the
Brazilian Amazon, an area of unstable malaria transmission where women are not immune
and respond clinically to a Plasmodium sp. infection, each episode of malaria exposes the
mother to the malaria paroxysm, which may be associated with increased uterine activity and
thus triggering a premature labour [17]. The studies of the mechanisms of P. vivax paroxysm
have shown all the cellular and noncellular mediators involved [37]. One of them is the pyro-
genic cytokine tumor necrosis factor (TNF)-α, which also has been shown to be increased in P.
falciparum placental malaria, and to be embryotoxic, cause necrosis of the implanted embryo,
and increase the risk of uterine contraction resulting in foetal expulsion [38].
In this study, as shown in Fig 2, most LBW babies were appropriate for gestational age
(between 10th and 90th percentiles), being only few of them (9%) below the 10th percentile
(IUGR). This is in smaller than IUGR rates reported in other Brazilian studies (13%) [39].
Hence, it seems that premature birth was the main responsible for LBW, and that the contribu-
tion of malaria infection to the impairment of foetal growth was less evident. This suggest that,
in areas of unstable malaria transmission where P. vivax predominates, prematurity appears to
be among the main detrimental outcomes of malaria in pregnancy, differently to what occurs
in P. falciparum areas where transmission is stable and LBW is the main outcome associated
with malaria infection in the pregnant woman followed by pre-term birth.
There are studies that indicate that male and female foetuses behave differently upon the
same adverse maternal environment, resulting in different foetal and neonatal morbidity and
mortality outcomes [30]. Studies showed that malaria in pregnancy was associated with
decreased mean birth weight of female newborns, but not of male newborns, and that female
fetus had a higher risk of IUGR compare to male [29, 40]. In contrast, in our cohort of new-
borns, sex specific differences in fetal growth (increased risk of IUGR) between female and
male newborns were seen (9.7% vs.8.1%), but these were not statistically different.
A limitation of this study was that birth weight was obtained from the SINASC system,
however, among a subsample of newborns, there was a high correlation between this weight
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and that collected from the newborn card by study staff. Gestation age was established by ultra-
sound in 61.2% (295/482) and it is known that last menstrual period is subject to reporting
bias. Other poor pregnancy outcomes in this study population such as miscarriage and still-
birth are reported elsewhere [17]. Also, it should be noted that the design of this study does not
permit to estimate the impact of P. vivaxmalaria on pregnancy outcomes, as a comparison
group of non-infected women were not enrolled.
In conclusion, this study shows that P. vivax is the prevailing species among malaria cases
in pregnant population in the region and shows that P. vivaxmalaria in pregnancy may repre-
sent detrimental consequences for the health of the mother and their offsprings particularly for
specific groups such as primigravidae, adolescents, and those with lower attendance to antena-
tal services with P. vivax clinical malaria during pregnancy. These groups deserve special atten-
tion in the design and deployment of preventive and curative strategies for malaria control
during pregnancy.
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